Page 24 - GTM-4-1

Global Translational Medicine

REVIEW ARTICLE
Synergizing phytonanotherapy and

complementary medicine: Future horizons in
cancer and diabetes care

Faheem Patwekar¹* , Mohsina Patwekar * , and
2
Mohammad Amjad Kamal 3,4,5,6
1 Department of Pharmacognosy, Luqman College of Pharmacy, PB 86, old Jewargi Road, Gulbarga,
Karnataka, India
2 Department of Pharmacology, Luqman College of Pharmacy, PB 86, old Jewargi Road, Gulbarga,
Karnataka, India
3 Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdul
rahman, University, Riyadh 11671, Saudi Arabia
4 Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University,
Birulia, Savar, Dhaka -1216, Bangladesh
5 Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of
Medical and Technical Sciences, Chennai,
Tamil Nadu, India
6 Novel Global Community Educational Foundation, Australia

*Corresponding authors:
Faheem Patwekar Abstract
(ifaheemp@gmail.com);
Mohsina Patwekar The intersection of phytonanotherapy, complementary and alternative medicine
(mohsina.patwekar@gmail.com)
(CAM), and nanoparticles (NPs) promises an exciting new area in cancer and diabetes
Citation: Patwekar F, Patwekar M, treatment. The CAM has attracted international recognition, emphasizing natural
Kamal MA. Synergizing
phytonanotherapy and therapies and holistic health. Phytonanotherapy uses the promise of environmentally
complementary medicine: Future safe and sustainable green synthesis processes to develop NPs rich in bioactive chemicals
horizons in cancer and diabetes originating from plants. These NPs provide a novel approach to targeted drug delivery,
care. Global Transl Med.
2025:4(1):16-34. diagnostics, and therapy. Personalized medicine, tailoring therapies to individual genetic
doi: 10.36922/gtm.5840 profiles and illness features, will most certainly be a cornerstone of these approaches in
the future. The accuracy of NP-based drug delivery systems offers improved treatment
Received: November 11, 2024
outcomes while lowering systemic toxicity. Advanced diagnostics based on NPs and
Revised: December 24, 2024 biosensors will enable early disease identification and real-time therapy response
Accepted: January 3, 2025 monitoring. Furthermore, combining CAM principles with NP-based therapies has great
promise for holistic care. Combination therapies combining traditional medicine with
Published online: January 22,
2025 cutting-edge nanomedicine have the potential to revolutionize cancer and diabetes
care. These medicines will become more widely available provided an improvement in
Copyright: © 2025 Author(s).
This is an Open-Access article the regulatory approval process and accessibility. Individual preferences and well-being
distributed under the terms of the will be prioritized in patient-centered care, promoting a range of treatment options.
Creative Commons Attribution Collaboration between practitioners of traditional medicine, researchers, artificial
License, permitting distribution,
and reproduction in any medium, intelligence experts, and healthcare providers will improve complete and integrative
provided the original work is health care. Green synthesis technologies will improve the efficiency and scalability of
properly cited. NP production. However, greater public and professional awareness is needed through
Publisher’s Note: AccScience educational initiatives to highlight the benefits and potential of CAM, phytonanotherapy,
Publishing remains neutral with and NP-based treatments. To summarize, the future of CAM, phytonanotherapy, and
regard to jurisdictional claims in
published maps and institutional NPs in cancer and diabetes treatment is bright since they provide patients with a variety
affiliations. of options while also contributing to more effective, sustainable, and patient-centered

Volume 4 Issue 1 (2025) 16 doi: 10.36922/gtm.5840